Tag: dea cannabis

DEA Approves THC Medicine for Schedule 2

The Drug Enforcement Administration (DEA) has given approval to a pharmaceutical THC product. After waiting roughly two years, the pharmaceutical drug company Insys has received approval from the DEA for their product Syndros. Syndros, according to Westword, is “an oral remedy containing THC”, which has been approved to treat nausea and vomiting, particular for cancer …

Continue reading

After Months of Public and Legal Pressure, DEA Removes Marijuana Misinformation from Website

The Drug Enforcement Administration (DEA) has removed marijuana misinformation from their website following months of public and legal pressure. After months of public pressure, and a legal request by the nonprofit medical cannabis advocacy group Americans for Safe Access, the DEA has removed factually inaccurate information about marijuana from their website. As part of the …

Continue reading

DEA Makes Decision on Whether or Not to Reschedule Cannabis

Despite earlier reports that the DEA was set to reschedule cannabis this month, the agency has announced that they will retain cannabis as a Schedule 1 controlled substance, while easing restrictions on those wanting to research the plant. In reaching its conclusion, the DEA says that an evaluation shows that cannabis has no ‘‘currently accepted …

Continue reading